CME webinar series: Addiction Care for the Non-Addiction Provider
Sep. 2022Education/Webinars
"CME webinar series: Addiction Care for the Non-Addiction Provider
September is National Recovery Month, and you are invited to watch a timely, CME-accredited webinar series on the topic. Michael Lynch, MD, Medical Director, Pittsburgh Poison Center; Medical Director, UPMC Health Plan Substance Use Disorder Services; and Associate Professor of Emergency Medicine, Toxicology, Pediatrics, and Addiction at the University of Pittsburgh, leads this four-part series.
Watch these recorded webinars to build your knowledge base:
*Provider is responsible for verifying CME eligibility. *This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
-
Part 1: Screening and initial intervention
Learn about the physiology, stigma, and effects of substance use disorder, among other topics related to screening and intervention. -
Part 2: Alcohol use disorder management
Learn about medication management and non-medication interventions, among other aspects of alcohol use disorder. -
Part 3: Opioid use disorder management
Learn about recommending medications for opioid use disorder (MOUD) and different MOUD options, among other aspects of opioid use disorder. -
Part 4: Overview of management and available resources
Learn about continuum of care for a patient with a substance use disorder including available resources to assist non-addiction providers to meet the needs of these patients.
*Provider is responsible for verifying CME eligibility. *This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
Recent Announcements
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates
Medicaid provider update: High-cost Medicaid drug billing
Billing requirements for Medicaid-covered drugsNov. 2025Important Notices
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Nov. 2025Education/Webinars